Wen Qu

Wen Qu is an experienced professional in the field of preclinical research, currently serving as the Director of Preclinical Research at 远大医药（中国）有限公司 since August 2021. Wen Qu has held the position of Study Director at HBCDC since April 2013, where responsibilities include designing study protocols, implementing them with technicians, interpreting results, and drafting study reports. Prior to this, Wen Qu worked as a Study Director at WuXi AppTec from November 2008 to April 2013. Educational qualifications include a Ph.D. in Drug Toxicology from Wuhan University (2015-2018), a Master's in Pharmacology from Wuhan University (2001-2004), and a Bachelor's in Clinical Medicine from Hubei Medical University (1994-1999).